Hypofractionated whole-breast irradiation (HF-WBI) is a method of delivering radiation therapy after breast-conserving surgery. The treatment is highly efficient, less expensive, and takes less time; however, it is not currently the standard method of radiotherapy in the United States. Recent research from the
University of Chicago Medicine Comprehensive Cancer Center examined challenges to more widespread adoption of HF-WBI, suggesting ways to address them so more women in the U.S. can benefit from this new treatment.
[READ MORE]
